Association Between Hepatitis C Infection and Renal Cell Carcinoma

Completed

• Conditions: Hepatitis C; Renal Cell Carcinoma; Colorectal Cancer

• Registration Number: NCT01405183
• Lead Sponsor: Henry Ford Health System

Brief Summary

The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer patients. Both groups would be of recent diagnosis (6 months).

Detailed Description

Not available

Study Timeline

• Study Start: 2011-01
• Study First Submitted: 2011-07-28
• Study First Submitted QC: 2011-07-28
• Study First Posted: 2011-07-29
• Primary Completion: 2013-08
• Study Completion: 2013-09
• Status Verified: 2014-09
• Last Update Submitted: 2014-09-16
• Last Update Posted: 2014-09-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

• Male and female patients 18 years or older in whom renal cell carcinoma is suspected and are scheduled for either biopsy or partial or total nephrectomy. Diagnosis within 6 months.
• Male and female patients 18 years or older in whom colorectal cancer has been diagnosed within the last 6 months

Exclusion Criteria

• Patients who are unwilling to provide consent
• Patients who decline to complete a questionnaire
• Patient in who blood sample cannot be obtained
• Diagnosis of renal cell carcinoma or colon cancer greater than 6 months

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of hepatitis C in renal cell carcinoma patients	2 years	Determine the prevalence of hepatitis C infection in newly diagnosed renal cell carcinoma patients

Trial Locations

Locations (1)

Henry Ford Hospital; 🇺🇸 Detroit, Michigan, United States